40 related articles for article (PubMed ID: 12796932)
1. Early prediction of uteroplacental complications of pregnancy using Doppler ultrasound, placental function tests and combination testing.
Bewley S; Chard T; Grudzinskas G; Cooper D; Campbell S
Ultrasound Obstet Gynecol; 1992 Sep; 2(5):333-7. PubMed ID: 12796932
[TBL] [Abstract][Full Text] [Related]
2. Screening for pre-eclampsia and small for gestational age fetuses at the 11-14 weeks scan by uterine artery Dopplers.
Pilalis A; Souka AP; Antsaklis P; Basayiannis K; Benardis P; Haidopoulos D; Papantoniou N; Mesogitis S; Antsaklis A
Acta Obstet Gynecol Scand; 2007; 86(5):530-4. PubMed ID: 17464579
[TBL] [Abstract][Full Text] [Related]
3. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.
Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381
[TBL] [Abstract][Full Text] [Related]
4. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
[TBL] [Abstract][Full Text] [Related]
5. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
6. [Sucessful pregnancy outcome following three severe placental abruptions and intrauterine fetal death in the patient--heterozygous carrier of R506Q mutation of factor V (Leiden)].
Dimitrova V; Koleva R; Savov A; Chernev T; Khranov Iu; Georgiev G; Slŭncheva B; Raĭcheva S
Akush Ginekol (Sofiia); 2004; 43(5):47-54. PubMed ID: 15518286
[TBL] [Abstract][Full Text] [Related]
7. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
[TBL] [Abstract][Full Text] [Related]
8. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.
Cowans NJ; Spencer K; Meiri H
Prenat Diagn; 2008 Feb; 28(2):121-5. PubMed ID: 18186153
[TBL] [Abstract][Full Text] [Related]
9. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
10. Doppler velocimetry of the uterine artery as a screening test for gestational hypertension.
Valensise H; Bezzeccheri V; Rizzo G; Tranquilli AL; Garzetti GG; Romanini C
Ultrasound Obstet Gynecol; 1993 Jan; 3(1):18-22. PubMed ID: 12796896
[TBL] [Abstract][Full Text] [Related]
11. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders.
Goetzinger KR; Singla A; Gerkowicz S; Dicke JM; Gray DL; Odibo AO
Am J Obstet Gynecol; 2009 Oct; 201(4):412.e1-6. PubMed ID: 19716535
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of biophysical fetal assessment in high-risk pregnancy to assess ultrasound parameters suitable for screening in the low-risk population.
Sim D; Beattie RB; Dornan JC
Ultrasound Obstet Gynecol; 1993 Jan; 3(1):11-7. PubMed ID: 12796895
[TBL] [Abstract][Full Text] [Related]
13. Individualized norms of optimal fetal growth: fetal growth potential.
Bukowski R; Uchida T; Smith GC; Malone FD; Ball RH; Nyberg DA; Comstock CH; Hankins GD; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2008 May; 111(5):1065-76. PubMed ID: 18448737
[TBL] [Abstract][Full Text] [Related]
14. Maternal insulin-like growth factor-I levels (IGF-I) reflect placental mass and neonatal fat mass.
Clapp JF; Schmidt S; Paranjape A; Lopez B
Am J Obstet Gynecol; 2004 Mar; 190(3):730-6. PubMed ID: 15042006
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.
Lambropoulou M; Tamiolakis D; Venizelos J; Liberis V; Galazios G; Tsikouras P; Karamanidis D; Petrakis G; Constantinidis T; Menegaki M; Papadopoulos N
Clin Exp Med; 2006 Dec; 6(4):171-6. PubMed ID: 17191109
[TBL] [Abstract][Full Text] [Related]
16. Transabdominal uterine artery Doppler between 11 and 14 weeks of gestation for the prediction of outcome in high-risk pregnancies.
Fratelli N; Rampello S; Guala M; Platto C; Frusca T
J Matern Fetal Neonatal Med; 2008 Jun; 21(6):403-6. PubMed ID: 18570118
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of microparticles at 24 weeks of gestation do not predict subsequent pregnancy complications.
Salomon O; Katz BZ; Dardik R; Livnat T; Steinberg DM; Achiron R; Seligsohn U
Fertil Steril; 2009 Aug; 92(2):682-7. PubMed ID: 18692836
[TBL] [Abstract][Full Text] [Related]
18. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease?
Ananth CV; Peltier MR; Kinzler WL; Smulian JC; Vintzileos AM
Am J Obstet Gynecol; 2007 Sep; 197(3):273.e1-7. PubMed ID: 17826417
[TBL] [Abstract][Full Text] [Related]
19. Endocrine assessments of fetal-placental well-being.
Tulchinsky D
Clin Perinatol; 1983 Oct; 10(3):763-76. PubMed ID: 6197223
[TBL] [Abstract][Full Text] [Related]
20. The use of placental function tests in a London teaching hospital.
Jackson P; Gouldes D
Br J Clin Pract; 1982 Dec; 36(11-12):375-8. PubMed ID: 7165766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
